封面
市场调查报告书
商品编码
1699444

全球抗组织胺市场按药物类别、剂型、适应症、给药途径、类型、分销管道和地区划分

Global Antihistamine Drugs Market, By Drug Class, By Form, By Indication, By Route of Administration, By Type, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球抗组织胺市场规模为 1,017.4 亿美元,到 2032 年将达到 1,678 亿美元,2025 年至 2032 年的年复合成长率为 7.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 1017.4亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 7.40% 2032年价值预测 1678亿美元
数字。全球市场占有率(按地区划分)(2025年)
全球抗组织胺市场-IMG1

抗组织胺是一种用于治疗打喷嚏、发痒、流鼻水和流泪等过敏症状的药物。这些药物透过阻断组织胺(人体在过敏反应过程中释放的一种物质)的作用而发挥作用。抗组织胺药物主要有两种:第一代抗组织胺和第二代抗组织胺。抗组织胺可透过柜檯购买,也可透过处方购买,其种类和强度各不相同。它有多种形式,包括锭剂、胶囊、液体、滴鼻剂和眼药水。

市场动态:

由于过敏症盛行率上升、新产品推出以及创新配方的核准,预计抗组织胺市场在预测期内将显着增长。例如,2021 年 6 月,美国食品药物管理局透过称为部分处方药到非处方药转换的流程核准了一种非处方鼻用抗组织胺。美国FDA核准Astepro(盐酸氮卓斯汀鼻喷雾,0.15%)用于治疗6岁及以上成人和儿童的季节性和常年性过敏性鼻炎(也称为过敏症)。

本研究的主要特点

  • 本报告对全球抗组织胺市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模和复合年增长率。
  • 它还强调了不同领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球抗组织胺市场的主要企业根据以下参数进行分析,例如公司亮点、产品系列、主要亮点、绩效和策略。
  • 研究涉及的主要企业包括拜耳公司、Almirall 公司、葛兰素史克公司、强生公司、赛诺菲公司、辉瑞公司、太阳製药工业有限公司、默克公司、梯瓦製药工业有限公司、雅培实验室、Viatris 公司、Arlak Biotech、Aden Healthcare、山德士集团、Hikma Pharmaceuticals PLC、莱迪uticals、PLC、雷迪士集团、西普拉西博士等实验室。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、高端市场策略、市场扩张和行销策略做出明智的决策。
  • 全球抗组织胺药物市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过用于分析全球抗组织胺市场的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件

第二章 市场概述

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 市场机会蓝图

第三章 关键见解

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • PEST分析
  • 波特分析
  • 技术进步
  • 合併、收购和合作场景
  • 近期产品核可
  • 公司市场占有率分析
  • 确定每个地区的主要企业
  • 进出口分析
  • 监管情景
  • 定价分析
  • 产品召回

4. 2020 年至 2032 年全球抗组织胺市场(依药物类别划分)

  • H-1抗组织胺药
  • 第一代
  • 第二代
  • H-2抗组织胺药

5. 全球抗组织胺市场(依形式),2020 年至 2032 年

  • 液体
  • 药片
  • 胶囊
  • 凝胶
  • 鼻喷剂
  • 其他的

6. 全球抗组织胺市场(依适应症划分),2020 年至 2032 年

  • 过敏性疾病
  • 胃肠道疾病
  • 中枢神经系统疾病
  • 皮肤病
  • 其他的

7. 全球抗组织胺市场(依给药途径),2020 年至 2032 年

  • 口服
  • 肠外
  • 其他的

8. 2020 年至 2032 年全球抗组织胺市场(按类型)

  • 非处方药
  • 处方笺

9. 全球抗组织胺市场(依分销管道划分),2020-2032 年

  • 医院药房
  • 网路药局
  • 零售药局

第 10 章。 2020 年至 2032 年按地区分類的全球抗组织胺市场

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第 11 章公司简介-全球抗组织胺市场

  • GlaxoSmithKline
    • 公司简介
    • 产品/服务组合
    • 财务表现
    • 最新动态/更新
    • 策略概述
  • Bayer AG
  • Almirall SA
  • Johnson and Johnson
  • Sanofi
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Merck &Co. Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Abbott Laboratories
  • Viatris Inc.
  • Arlak Biotech
  • Aden Healthcare
  • Sandoz Group AG
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories
  • Cipla

第十二章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI6700

Global Antihistamine Drugs Market is estimated to be valued at USD 101.74 Bn in 2025 and is expected to reach USD 167.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 101.74 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.40% 2032 Value Projection: USD 167.80 Bn
Figure. Global Antihistamine Drugs Market Share (%), By Region 2025
Global Antihistamine Drugs Market - IMG1

Antihistamine drugs are a class of medications that are used to treat symptoms of allergies, such as sneezing, itching, runny nose, and watery eyes. These drugs work by blocking the action of histamine, a substance in the body that is released during an allergic reaction. There are two main types of antihistamines: First-generation antihistamines and second-generation antihistamine. Antihistamines are available over-the-counter and by prescription, depending on the specific medication and its strength. They come in various forms, including tablets, capsules, liquids, nasal sprays, and eye drops.

Market Dynamics:

The antihistamine drugs market is expected to witness significant growth over the forecast period owing to rise in the prevalence of allergies coupled, new product launches and approvals of innovative formulations. For instance, in June 2021, the U.S. Food and Drug Administration approved a nasal antihistamine for nonprescription use through a process known as a partial prescription to nonprescription switch. The U.S. FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis (also known as allergies) in adults and children aged six and older.

Key Features of the Study:

  • This report provides an in-depth analysis of the global antihistamine drugs market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global antihistamine drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Bayer AG, Almirall, S.A, GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer Inc., Sun Pharmaceutical Industries Limited, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, and Cipla
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global antihistamine drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antihistamine drugs market

Detailed Segmentation:

  • By Drug Class:
    • H-1 Antihistamines
    • First-generation
    • Second-generation
    • H-2 Antihistamines
  • By Form:
    • Liquid
    • Tablets
    • Capsules
    • Gels
    • Nasal Sprays
    • Others
  • By Indication:
    • Allergic Disorders
    • Gastrointestinal Disorders
    • Central Nervous System Disorders
    • Dermatological Disorders
    • Others
  • By Route of Administration:
    • Oral
    • Parenteral
    • Others
  • By Type:
    • OTC
    • Prescription
  • By Distribution Channel:
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Bayer AG
    • Almirall S.A
    • GlaxoSmithKline
    • Johnson and Johnson
    • Sanofi
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Limited
    • Merck & Co. Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Abbott Laboratories
    • Viatris Inc.
    • Arlak Biotech
    • Aden Healthcare
    • Sandoz Group AG
    • Hikma Pharmaceuticals PLC
    • Reddy's Laboratories
    • Cipla

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Form
    • Market Snapshot, By Indication
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancements
  • Merger, Acquisition, and Collaboration Scenario
  • Recent Product Approvals
  • Company Market Share Analysis
  • Identification of Key Players in Each Region
  • Import-Export Analysis
  • Regulatory Scenario
  • Pricing Analysis
  • Product Recalls

4. Global Antihistamine Drugs Market, By Drug Class, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • H-1 Antihistamines , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • First-generation, 2020 - 2032(US$ Billion)
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Second-generation, 2020 - 2032(US$ Billion)
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • H-2 Antihistamines , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

5. Global Antihistamine Drugs Market, By Form, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Liquid, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Tablets, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Capsules, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Gels, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Nasal Sprays, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

6. Global Antihistamine Drugs Market, By Indication, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Allergic Disorders, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Gastrointestinal Disorders, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Central Nervous System Disorders, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Dermatological Disorders, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

7. Global Antihistamine Drugs Market, By Route of Administration, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Oral, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Parenteral, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

8. Global Antihistamine Drugs Market, By Type, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • OTC, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Prescription, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

9. Global Antihistamine Drugs Market, By Distribution Channel, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Online Pharmacies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Retail Pharmacies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

10. Global Antihistamine Drugs Market, By Region, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Asean
      • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
      • South Africa
      • North Africa
      • Central Africa

11. Company Profiles - Global Antihistamine Drugs Market

  • GlaxoSmithKline *
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Bayer AG
  • Almirall S.A
  • Johnson and Johnson
  • Sanofi
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Merck & Co. Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Abbott Laboratories
  • Viatris Inc.
  • Arlak Biotech
  • Aden Healthcare
  • Sandoz Group AG
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories
  • Cipla

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact